Stocks
ALX Oncology Holdings (ALXO) P/E US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -10.4 | -3.71 | -3.98 | -0.65 | -0.60 | -1.23 | ||
| Changes by years, y/y, % | -86% | -64% | +7% | -84% | -8% | -62.0% | |||
ALX Oncology Holdings. P/E
ALX Oncology Holdings. P/E, changes, %
ALX Oncology Holdings (ALXO) P/E US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| P/E | ? | -0.26 | -0.19 | -0.91 | -0.60 | -1.23 | -1.23 | |
| Changes by years, y/y, % | -92% | -90% | +43% | -8% | +380% | |||
| Changes by quarters, q/q, % | -61% | -26% | +377% | -34% | +104% | |||
